CATRINA WOLFE: Open Payments
NPI 1053405696 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 53 payments from 13 companies in 2025. Trend: 2023 $1,870 · 2024 $1,449 · 2025 $1,618
Food & beverage: $1,618
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $232 |
| Alnylam Pharmaceuticals Inc. | 4 | $220 |
| Abbott Laboratories | 4 | $211 |
| Boston Scientific Corporation | 3 | $204 |
| Novartis Pharmaceuticals Corporation | 7 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $138 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| SCPHARMACEUTICALS INC. | 4 | $116 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| PFIZER INC. | 3 | $57 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, FARAPULSE, AMVUTTRA, LEQVIO, JARDIANCE, FARXIGA, FUROSCIX, ELIQUIS.
Industry payments across PA — which companies pay providers there.
